Exomind TMS for Depression Treatment
Exomind is a non-invasive treatment that uses magnetic stimulation to activate areas of the brain involved in mood regulation.
At iCare Medical Group, this treatment may be discussed with adults who have major depressive disorder and have not had enough improvement with antidepressant medication during the current depressive episode.
Non-Invasive Depression Care
A structured, physician-guided option for patients who want to explore depression treatment without anesthesia or recovery downtime.
Who This Treatment May Help
This option may be considered for adults whose depression symptoms and treatment history suggest that a non-invasive treatment evaluation may be a reasonable next step.
- Adults with major depressive disorder
- Patients who have not had enough improvement with antidepressant medication
- Patients looking for a non-invasive treatment option
- Patients who can follow a structured treatment series and follow-up plan
- Patients who want physician-guided review of risks, fit, and expectations
Treatment Experience
What Treatment Is Like
Treatment is performed in the office while you sit comfortably. Sessions are brief, patients remain awake, and most people can return to normal daily activity afterward. This is not a one-visit treatment. Planning depends on medical history, psychiatric history, safety screening, and the physician-guided protocol selected for the patient.
Your care team will explain what to expect before treatment begins, including the visit schedule, safety considerations, and how progress may be monitored over time.
Insurance & Trusted Partners
We accept many major plans. Not sure if you’re covered? Call and we’ll help verify your benefits before your visit.
Treatment + Device Spotlight
A Physician-Guided Treatment Experience Designed to Support Depression Care
This non-invasive option may be considered for adults with depression who want to explore a structured care plan after not having enough improvement with prior medication. The goal is not to replace thoughtful evaluation. The goal is to help determine whether this approach fits the patient’s diagnosis, treatment history, safety profile, and care goals.
BTL Exomind TMS Platform
Exomind uses transcranial magnetic stimulation to activate targeted brain regions involved in mood regulation without anesthesia, sedation, or recovery downtime.
- FDA-cleared in the U.S. for adult patients with major depressive disorder
- Non-invasive magnetic stimulation delivered in the office
- Sessions are typically under 30 minutes
- Walk-in and walk-out care with no anesthesia or recovery time
- Physician-guided review before treatment begins
Non-Invasive Depression Treatment
Exomind does not require surgery, anesthesia, or systemic medication exposure during the session itself.
Brief Office-Based Sessions
Visits are typically under 30 minutes, which may make treatment easier to fit around work and normal routines.
Candidacy Review First
The care team reviews depressive symptoms, treatment history, safety factors, and whether this option is appropriate before starting.
How We Approach This Care
Our approach begins with careful screening and thoughtful discussion. We review diagnosis, prior treatment response, current medications, symptom severity, and practical safety questions before deciding whether this treatment may be an appropriate next step.
Candidacy involves more than interest alone. Implanted electronic devices, certain metal near the head, seizure history, or other neurological and psychiatric considerations may affect whether treatment is appropriate.
This Type of Evaluation Is Often Discussed Alongside:
- Review of depression history and prior treatment response
- Discussion of whether this option fits the current care plan
- Safety screening for implants, metal, and neurological history
- Clear expectations around the treatment series, follow-up, and response monitoring